SPIRO 2110
Alternative Names: SPIRO-2110Latest Information Update: 18 Jul 2023
At a glance
- Originator Spirovant Sciences
- Class Antifibrotics; Gene therapies
- Mechanism of Action Cystic fibrosis transmembrane conductance regulator expression modulators; Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Cystic fibrosis
Most Recent Events
- 01 Sep 2020 Early research in Cystic fibrosis in USA (Inhalation), (Spirovant Sciences pipeline, September 2020)